NCT00000153View on ClinicalTrials.gov

Krypton-Argon Regression of Neovascularization Study (KARNS)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1984

Conditions

Diabetic RetinopathyRetinal NeovascularizationDiabetes Mellitus

Interventions

PROCEDURE

Blue-Green Argon Laser Treatment

PROCEDURE

Red Krypton Laser Treatment

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00000153 - Krypton-Argon Regression of Neovascularization Study (KARNS) | Biotech Hunter | Biotech Hunter